亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

上海安奈德化學(xué)技術(shù)中心  

生物制品,分析試劑,技術(shù)咨詢與服務(wù)

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:余偉
  • 電話:021-39541623
  • 郵件:2524132229@qq.com
  • QQ:2524132229
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 二氫楊梅素對照品
二氫楊梅素對照品
單價 1.00 / 支對比
銷量 暫無
發(fā)貨 上海付款后48小時內(nèi)
庫存 100支起訂1支
品牌 阿生納
型號 27200-12-0
規(guī)格 HPLC≥98.0%
過期 長期有效
更新 2013-05-08 09:19
 
詳細信息
 英文名:Dihydromyricetin 
別名:(+)-Dihydromyricetin; Ampelopsin; (2R,3R)-3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-4-one 
產(chǎn)品名稱:二氫楊梅素; (2R,3R)-3,5,7-三羥基-2-(3,4,5-三羥基苯基)苯并二氫吡喃-4-酮 
分子式:C15H12O8 
分子量:320.25 
CAS:27200-12-0 
©2025 上海安奈德化學(xué)技術(shù)中心 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:11282  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |